Blog
About

1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      ROBUST: First report of phase III randomized study of lenalidomide/R-CHOP (R2 -CHOP) vs placebo/R-CHOP in previously untreated ABC-type diffuse large B-cell lymphoma

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          Hematological Oncology
          Hematol Oncol
          Wiley
          02780232
          June 2019
          June 2019
          June 12 2019
          : 37
          : 36-37
          Affiliations
          [1 ]Division of Hematology; A.O.U. Città della Salute e della Scienza Hospital and University; Torino Italy
          [2 ]Division of Hematology; Mayo Clinic; Rochester MN United States
          [3 ]Centre for Lymphoid Cancer; British Columbia Cancer; Vancouver BC Canada
          [4 ]Harbin Medical University Cancer Hospital; Harbin Heilongjiang China
          [5 ]Department of Hematology; Jagiellonian University; Krakow Poland
          [6 ]Department of Hematology; Ankara University; Ankara Turkey
          [7 ]Cancer Hospital; Fudan University; Shanghai China
          [8 ]Beijing Cancer Hospital; Beijing China
          [9 ]The First Affiliated Hospital of Medical School of Zhejiang University; First Hospital of Zhejiang Province; Zhejiang Hangzhou China
          [10 ]Fourth Department of Internal Medicine-Hematology; Charles University Hospital and Faculty of Medicine; Hradec Králové Czech Republic
          [11 ]Servicio de Hematologia; Hospital Universitario San Pedro de Alcántara; Cáceres Spain
          [12 ]Division of Hematology, Department of Medicine; University of Padova and Azienda Ospedaliera di Padova; Padova Italy
          [13 ]Department of Internal Medicine and Haematology; Faculty Hospital Kralovske Vinohrady; Prague Czech Republic
          [14 ]UO Ematologia; Ospedale Degli Infermi; Rimini Italy
          [15 ]Department of Oncology, Asan Medical Center; University of Ulsan College of Medicine; Seoul South Korea Republic of Korea
          [16 ]AOU Città della Salute e della Scienza di Torino; Turin Italy
          [17 ]U.O. Ematologia, Dipartimento Oncologia e Ematologia; Ospedale Santa Maria delle Croci; Ravenna Italy
          [18 ]National Cancer Center Hospital; Tokyo Japan
          [19 ]Department of Medicine and Biosystemic Science; Kyushu University Faculty of Medicine; Fukuoka City Japan
          [20 ]Clinical Research & Development; Celgene Corporation; Summit NJ USA
          10.1002/hon.5_2629
          © 2019

          http://doi.wiley.com/10.1002/tdm_license_1.1

          http://onlinelibrary.wiley.com/termsAndConditions#vor

          Comments

          Comment on this article